BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR; Practice Parameters Committee of the American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol 2021;116:878-98. [PMID: 33929376 DOI: 10.14309/ajg.0000000000001259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lewis JH. Digitizing DILI: Who can? RUCAM? RECAM? Hepatology 2022. [PMID: 34990036 DOI: 10.1002/hep.32312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Woo SM, Alhaqqan DM, Gildea DT, Patel PA, Cundra LB, Lewis JH. Highlights of the drug-induced liver injury literature for 2021. Expert Rev Gastroenterol Hepatol 2022. [PMID: 35839342 DOI: 10.1080/17474124.2022.2101996] [Reference Citation Analysis]
3 Benić MS, Nežić L, Vujić-Aleksić V, Mititelu-Tartau L. Novel Therapies for the Treatment of Drug-Induced Liver Injury: A Systematic Review. Front Pharmacol 2021;12:785790. [PMID: 35185538 DOI: 10.3389/fphar.2021.785790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Varma S, Nathanson J, Dowlatshahi M, Del Portillo A, Ramirez I, Garcia-Carrasquillo R. Doxycycline-induced cholestatic liver injury. Clin J Gastroenterol 2021. [PMID: 34228348 DOI: 10.1007/s12328-021-01475-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gerbes AL. Drug-Induced Liver Injury (DILI): A Major Challenge. Drug Res (Stuttg) 2021;71:S7. [PMID: 34788876 DOI: 10.1055/a-1606-5411] [Reference Citation Analysis]
6 Jiang Z, Zhao C, Li X, Yi W, Yan R. Liver failure caused by intravenous amiodarone and effective intervention measures: A case report. J Clin Pharm Ther 2022. [PMID: 35322453 DOI: 10.1111/jcpt.13647] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Weber S, Gerbes AL. Challenges and Future of Drug-Induced Liver Injury Research-Laboratory Tests. Int J Mol Sci 2022;23:6049. [PMID: 35682731 DOI: 10.3390/ijms23116049] [Reference Citation Analysis]
8 Ordway S, Sadowski B, Driggers KE, Kwok R. Severe Drug-Induced Liver Injury in the Military: A Retrospective Review. Mil Med 2021:usab445. [PMID: 34697623 DOI: 10.1093/milmed/usab445] [Reference Citation Analysis]
9 Kulkarni AV, Tirumalle S, Premkumar M, Kumar K, Fatima S, Rapole B, Simhadri V, Gora BA, Sasikala M, Gujjarlapudi D, Yelamanchili S, Sharma M, Gupta R, Rao PN, Reddy DN. Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial. Am J Gastroenterol 2022;117:607-16. [PMID: 35041634 DOI: 10.14309/ajg.0000000000001611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Pohl J, Bischoff P, Oellinger R, Schoening W, Lurje G, Pratschke J, Horst D, Tacke F, Wree A. Liver Transplantation and the Use of Metamizole to Treat Drug-induced Liver Injury. Transplant Proc 2022:S0041-1345(22)00422-5. [PMID: 35933233 DOI: 10.1016/j.transproceed.2022.04.028] [Reference Citation Analysis]
11 Ye C, Li W, Li L, Zhang K. Glucocorticoid Treatment Strategies in Liver Failure. Front Immunol 2022;13:846091. [PMID: 35371046 DOI: 10.3389/fimmu.2022.846091] [Reference Citation Analysis]
12 Zhou Y, Wang J, Zhang D, Liu J, Wu Q, Chen J, Tan P, Xing B, Han Y, Zhang P, Xiao X, Pei J. Mechanism of drug-induced liver injury and hepatoprotective effects of natural drugs. Chin Med 2021;16:135. [PMID: 34895294 DOI: 10.1186/s13020-021-00543-x] [Reference Citation Analysis]
13 Tan CK, Ho D, Wang LM, Kumar R. Drug-induced autoimmune hepatitis: A minireview. World J Gastroenterol 2022; 28(24): 2654-2666 [DOI: 10.3748/wjg.v28.i24.2654] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Weber S, Gerbes AL. Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment. Am J Gastroenterol 2021;116:2151-2. [PMID: 34187981 DOI: 10.14309/ajg.0000000000001369] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ferreira CM, Vasconcelos-Pereira EF, Oliveira VM, Salgado PR, Domingos JA, Monreal MTFD, Guerra-Shinohara EM, Gubert VT. Hepatotoxicity associated with the use of teriflunomide in a patient with multiple sclerosis: A case report. Medicine (Baltimore) 2021;100:e28246. [PMID: 34941096 DOI: 10.1097/MD.0000000000028246] [Reference Citation Analysis]
16 Long MD, Bajaj JS. The American Journal of Gastroenterology in 2022 and Beyond: A Vision for "Our" Journal. Am J Gastroenterol 2021. [PMID: 34904963 DOI: 10.14309/ajg.0000000000001579] [Reference Citation Analysis]
17 Li M, Luo Q, Tao Y, Sun X, Liu C. Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review. Front Pharmacol 2021;12:806249. [PMID: 35069218 DOI: 10.3389/fphar.2021.806249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, Gonzalez-Jimenez A, Yang Q, Gu J, Andrade RJ, Hoofnagle JH. A revised electronic version of RUCAM for the diagnosis of DILI. Hepatology 2022. [PMID: 35014066 DOI: 10.1002/hep.32327] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
19 Robles-Díaz M, Nezic L, Vujic-Aleksic V, Björnsson ES. Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review. Front Pharmacol 2021;12:744488. [PMID: 34776963 DOI: 10.3389/fphar.2021.744488] [Reference Citation Analysis]
20 Patel AD, Pinsker BL, Wall A, Arbogast M, King LY, Sherzoy S. Itching to find a diagnosis. Clinical Liver Disease. [DOI: 10.1002/cld.1230] [Reference Citation Analysis]
21 Li M, He Q, Yao L, Wang X, Tang Z, Zhu X, Lin HS, Xiang X. Simultaneous Quantification of Propylthiouracil and Its N-β-d Glucuronide by HPLC-MS/MS: Application to a Metabolic Study. Pharmaceuticals (Basel) 2021;14:1194. [PMID: 34832976 DOI: 10.3390/ph14111194] [Reference Citation Analysis]
22 Tu C, Xu Z, Tian L, Yu Z, Wang T, Guo Z, Zhang J, Wang T. Multi-Omics Integration to Reveal the Mechanism of Hepatotoxicity Induced by Dictamnine. Front Cell Dev Biol 2021;9:700120. [PMID: 34595163 DOI: 10.3389/fcell.2021.700120] [Reference Citation Analysis]
23 Liu L, Yang Y, Li W, Li Y, Jiang X, Wang L. Tanshinone IIA alleviate rifampicin-induced cholestasis by regulating the expression and function of bile salt export pump. Hum Exp Toxicol 2022;41:9603271221097365. [PMID: 35544702 DOI: 10.1177/09603271221097365] [Reference Citation Analysis]
24 Tan K, Yang W, Pang L, Hou F. Differences in clinical characteristics among 726 patients with Chinese herbal medicine- or Western medicine-induced liver injury. Medicine (Baltimore) 2022;101:e29909. [PMID: 35960048 DOI: 10.1097/MD.0000000000029909] [Reference Citation Analysis]
25 Tuteja S, Yu Z, Wilson O, Chen HC, Wendt F, Chung CP, Shah SC, Hunt CM, Suzuki A, Chanfreau C, Gorman BR, Joseph J, Luoh SW, Napolioni V, Robinson-Cohen C, Tao R, Zhou J, Chang KM, Hung AM; VA Million Veteran Program COVID-19 Science Initiative. Pharmacogenetic variants and risk of remdesivir-associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID-19. Clin Transl Sci 2022. [PMID: 35684976 DOI: 10.1111/cts.13313] [Reference Citation Analysis]
26 Contreras Omaña R, Moreno Alcántar R, Cerda Reyes E. Drug‐Induced Liver Injury: A Mexican View. Clinical Liver Disease 2022;19:78-81. [DOI: 10.1002/cld.1206] [Reference Citation Analysis]
27 Zhang K, Li J, Xin X, Du X, Zhao D, Qin C, Han X, Huo M, Yang L, Yin L. Dual Targeting of Cancer Cells and MMPs with Self-Assembly Hybrid Nanoparticles for Combination Therapy in Combating Cancer. Pharmaceutics 2021;13:1990. [PMID: 34959271 DOI: 10.3390/pharmaceutics13121990] [Reference Citation Analysis]
28 Philipose J, Suchman KI, Aronsky D, Lee T. A Case of Acute Liver Failure in a Patient on Isoniazid Prophylaxis for Latent Tuberculosis. Cureus. [DOI: 10.7759/cureus.22452] [Reference Citation Analysis]
29 Shi X, Lao D, Xu Q, Li X, Lv Q. A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale. BMC Infect Dis 2022;22:368. [PMID: 35410140 DOI: 10.1186/s12879-022-07258-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]